Solventum Corporation (SOLV)
Pre-Market:
| Previous Close | 65.01 |
| Open | 64.95 |
| Bid | 0.00 x 800 |
| Ask | 65.00 x 900 |
| Day's Range | 64.29 - 66.85 |
| 52 Week Range | 60.72 - 72.40 |
| Volume | |
| Avg. Volume | 3,273,391 |
| Market Cap | 11.252B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 69.50 |
PR NewswireSolventum Announces First Quarter 2024 Earnings Release Date and Upcoming Investor Events
Solventum (NYSE: SOLV) announced today that it will release carve-out financial results for the first quarter 2024 before the market opens on May 9, 2024. The earnings press release and accompanying materials will be available on the company's website at https://investors.solventum.com.
PR NewswireSolventum Names Shirley Edwards to Board of Directors
Solventum (NYSE: SOLV) announced today that its Board of Directors appointed Shirley Edwards, former partner, EY, to the board. Edwards will serve on Solventum's Audit and Talent committees, effective April 12, 2024.
- Yahoo Finance Video
Solventum completes spin off from 3M
Manufacturer 3M (MMM) has announced the completion of its healthcare spin-off Solventum (SOLV). The company has been in the process of spinning off from 3M since 2022 in the wake of lawsuits regarding the "forever chemical" PFAS (per and poly-fluoroalkyl substances). Solventum will join the S&P 500 (^GSPC). Yahoo Finance Anchors Josh Lipton and Julie Hyman break down the latest developments for both companies and how they may operate moving forward. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. Editor's note: This article was written by Nicholas Jacobino
